APOE genotype is a major predictor of long-term progression of disability in MS

Neurology

Volumn 56, Issue 3, 2001, Pages 312-316

  Chapman, J ^a,b   Vinokurov, S ^a   Achiron, A ^a,c   Karussis, D M ^d   Mitosek Szewczyk, K ^e   Birnbaum, M ^b   Michaelson, D M ^a   Korczyn, A D ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e Sch Med   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; LATENT PERIOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 0035852833     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.3.312     Document Type: Article

References (34)

1. Expression of apolipoprotein E during nerve degeneration and regeneration
2. Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells
3. Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures
4. Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor
5. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
6. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia
7. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele
8. Apolipoprotein E4 in Parkinson's disease and dementia: New data and meta-analysis of published studies
9. The APOE 4 allele and progression of disability in multiple sclerosis
10. Preliminary observations on APOE e4 allele and progression of disability in multiple sclerosis
11. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis
12. APOE geno-type of MS patients affects the severity of tissue destruction as seen on MRI
13. APOE geno-type and clinical course of MS: A cross-sectional study
14. Association study of two APOE polymorphisms in Italian MS patients
15. Severity and susceptibility of multiple sclerosis related to polymorphisms of apolipoprotein E
16. ApoE gene variants and a disease progression index in multiple sclerosis
17. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
18. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
19. HLA-antigens and the prognosis of multiple sclerosis
20. A simple and efficient method for apolipoprotein E genotype determination
21. APOE-e4 in age-related memory complaints and Alzheimer's disease
22. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients
23. Apo E geno-types in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease
24. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women
25. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability
26. Survival and predictors of disability in Turkish MS patients
27. The natural history of multiple sclerosis: A geographically based study. 3. Multivariate analysis of predictive factors and models of outcome
28. Progression index and disability status in multiple sclerosis: A resurvey of 207 patients in central Poland
29. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
30. The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects
31. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: Evidence for a major influence on the clinical presentation and prognosis
32. Preliminary report of a genetic basis for cognitive decline after cardiac operations
33. Axonal transection in the lesions of multiple sclerosis
34. The pathological evolution of multiple sclerosis